GLUE

Monte Rosa Therapeutics, Inc. - Common Stock (GLUE)

About Monte Rosa Therapeutics, Inc. - Common Stock (GLUE)

Monte Rosa Therapeutics, Inc. operates as a biotechnology company, which engages in the developing of precision medicines. The company was founded on November 21, 2019 and is headquartered in Boston, MA.

Details

Daily high

$10.58

Daily low

$10.13

Price at open

52 Week High

$25.77

52 Week Low

$9.68

Market cap

923.1M

Dividend yield

Volume

1,621

Avg. volume

1.5M

P/E ratio

-5.68

Monte Rosa Therapeutics, Inc. - Common Stock News